Truist Financial
RPRX icon

Truist Financial’s Royalty Pharma RPRX Stock Holding History

Truist Financial’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.14M Buy
36,623
+6,733
+23% +$397K ﹤0.01% 1348
2026
Q2 		$1.68M Buy
29,890
+782
+3% +$40.7K ﹤0.01% 1480
2026
Q1 		$1.4M Buy
29,108
+1,339
+5% +$58.6K ﹤0.01% 1524
2025
Q4 		$1.07M Buy
27,769
+303
+1% +$11.6K ﹤0.01% 1625
2025
Q3 		$969K Buy
27,466
+3,127
+13% +$113K ﹤0.01% 1685
2025
Q2 		$877K Buy
24,339
+847
+4% +$28.1K ﹤0.01% 1653
2025
Q1 		$731K Buy
23,492
+8,953
+62% +$284K ﹤0.01% 1673
2024
Q4 		$371K Buy
+14,539
New +$386K ﹤0.01% 2044
2024
Q3 		– Sell
-13,486
Closed -$356K – 2694
2024
Q2 		$356K Sell
13,486
-10,211
-43% -$283K ﹤0.01% 2198
2024
Q1 		$720K Buy
23,697
+7,909
+50% +$233K ﹤0.01% 1764
2023
Q4 		$443K Buy
+15,788
New +$434K ﹤0.01% 2061
2023
Q2 		– Sell
-38,731
Closed -$1.4M – 2658
2023
Q1 		$1.4M Buy
38,731
+486
+1% +$18K ﹤0.01% 1400
2022
Q4 		$1.51M Sell
38,245
-8,683
-19% -$362K ﹤0.01% 1345
2022
Q3 		$1.88M Buy
46,928
+34,103
+266% +$1.46M ﹤0.01% 1206
2022
Q2 		$539K Buy
+12,825
New +$526K ﹤0.01% 1864

Other funds holding RPRX

Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $106B AUM 2.29% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return
Royal London Asset Management
Royal London Asset Management United Kingdom $54.5B AUM 31.87% 1-Year Est. Return

Truist Financial's RPRX Position: Q3 2026 in Review

Truist Financial increased its Royalty Pharma (RPRX) stake by 23% in Q3 2026, buying an estimated $397K and bringing the position to 36,623 shares worth $2.14M. The position accounts for ﹤0.01% of the portfolio, ranked #1348.

Truist Financial first reported a position in RPRX in Q2 2022 and has held it in 15 quarters since. 517 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Truist Financial held 36,623 shares of Royalty Pharma worth $2.14M as of Q3 2026.
  • Truist Financial bought 6,733 Royalty Pharma shares in Q3 2026, an estimated $397K.
  • Royalty Pharma made up ﹤0.01% of Truist Financial's portfolio in Q3 2026, its #1348 holding.
  • Truist Financial first reported a position in Royalty Pharma in Q2 2022 and has held it in 15 quarters since.
  • 517 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Truist Financial's 13F filing for Q3 2026, filed 30 Oct 2026.